Ks 452 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ks 452. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ks 452 Today - Breaking & Trending Today

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

Published: March 8, 2023

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today it has ended its AKS-452 licensing, manufacturing, and commercialization agreement with Stelis Biopharma Limited, an arm of Strides Pharma Science Ltd.

Source: businesswireindia.com

Related Topics:

Todd ZionAkston BiosciencesJohnson JanssenAkston Biosciences CorporationStrides Pharma Science LtdMerck CoSmartcells IncStelis BiopharmaUnited StatesEmergency Use AuthorizationBiosciences CorporationStelis Biopharma LimitedStrides Pharma ScienceMedia ContactVaccine PartnershipOvid Universal BoosterKs 452Covid 19 VaccineEmergency Use AuthorizationAkston Biosciences CorporationTodd ZionMbifect Fc Fusion Protein